Priorix

GlaxoSmithKline Biologicals SA🇺🇸 United States

FDA Page

Effective Date: Nov 14, 2025
Approval ID: 95c6fdb6-b587-4413-92f9-d592b9f7a23e
Products: 1 registered
Version: 7

Regulatory Information

Labeling Type

VACCINE LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use PRIORIX safely and effectively. See full prescribing information for PRIORIX.PRIORIX (Measles, Mumps, and Rubella Vaccine, Live) for injectable suspension, for subcutaneous useInitial U.S. Approval: 2022

Quick Stats

Total Products1

Labelers2

Label Sections34

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.